Niklas Broman - UTU Research Portal

Niklas Broman

- Doctoral Researcher,
Internal Medicine (Department of Clinical Medicine)

nsbrom@utu.fi

Publications

Guidelines to practice in hospitals at home : safe and effective continuous infusion pumps substantially increased penicillin use in erysipelas treatment (2024)
- European Journal of Public Health
Metsä-Simola, Niina; Saarenketo, Jenni; Lehtonen, Henri; Broman, Niklas; Häggblom, Tony; Björklöf, Pia; Sariola, Salla; Valta, Maija P
(A1 Refereed original research article in a scientific journal)
Antibioottipumput vähentävät sairaalahoitoja (2023)
- Lääkärilehti
Lehtola Laura, Broman Niklas, Järvinen Asko
(D1 Article in a professional journal)
Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland (2023)
- BMC Infectious Diseases
Hänninen Janne, Anttalainen Ulla, Kilpeläinen Maritta, Hohenthal Ulla, Broman Niklas, Palmen Jenni, Oksi Jarmo, Feuth Thijs
(A1 Refereed original research article in a scientific journal)
Association of human myxovirus resistance protein A with severity of COVID-19 (2022)
- BMC Infectious Diseases
Lehtinen Otto, Broman Niklas, Waris Matti, Vuorinen Tytti, Peltola Ville, Löyttyniemi Eiisa, Oksi Jarmo, Feuth Thijs
(A1 Refereed original research article in a scientific journal)
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study (2022)
- Clinical Microbiology and Infection
Broman Niklas, Feuth Matthijs, Vuorinen Tytti, Valtonen Mika, Hohenthal Ulla, Löyttyniemi Eliisa, Hirvioja Tiina, Jalava-Karvinen Päivi, Marttila Harri, Nordberg Marika, Oksi Jarmo
(A1 Refereed original research article in a scientific journal)
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply (2022)
- Clinical Microbiology and Infection
Broman Niklas, Feuth Thijs, Oksi Jarmo; COVIDSTORM study group
(B1 Non-refereed article in a scientific journal)
Association between Administration of IL-6 Antagonists and Mortality among Patients Hospitalized for COVID-19: A Meta-analysis (2021)
- JAMA: Journal of the American Medical Association
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
(A2 Refereed review article in a scientific journal )
IL-6 and other biomarkers as predictors of severity in COVID-19 (2021)
- Annals of Medicine
Broman N, Rantasärkkä K, Feuth T, Valtonen M, Waris M, Hohenthal U, Rintala E, Karlsson A, Marttila H, Peltola V, Vuorinen T, Oksi J
(A1 Refereed original research article in a scientific journal)